Introduction
Human neonates are deficient in the ability to mount an efficient antibody response to antigenic challenge (1) . This (2) . This may reflect in part the diminished capacity of neonatal T cells to produce cytokines such as IL-4 and IFN-y (4-7). However, relatively little is known regarding the mechanism underlying the inability of neonatal T cells to provide contact-dependent help.
One receptor/ligand pair known to be important for induction of a full B cell response is CD40 and CD40 ligand (gp39).' B cells constitutively express CD40, and signals delivered via CD40 induce B cell proliferation (8, 9) , differentiation, and isotype switching in the presence of coactivation signals (10, 11) . B cells stimulated with anti-CD40 and IL-4 proliferate and differentiate by switching Ig class production from IgM to IgE (11) (12) (13) (14) . In contrast, IL-10 promotes immunoglobulin secretion primarily without inducing class switching, since IgD+ (naive) B cells cultured in the presence of anti-CD40 and IL-10 produce only IgM, and IgD-(mature) B cells secrete IgG, IgA, and IgM (15) . A soluble recombinant form of CD40 ligand (sgp39), if added to a B cell culture system, has an effect similar to anti-CD40 mAb on B cell proliferation and Ig synthesis (10, 16, 17) . The dependence of normal B cell function upon the presence of functional T cells reflects, at least in part, the expression of the ligand for CD40, gp39, by activated human T cells (18) (19) (20) (21) . The importance of this interaction is underscored by the finding that the molecular defect responsible for the hyper IgM syndrome is a functionally defective CD40 ligand, resulting in the failure of B cells to switch from IgM to IgA and IgG production (16, (22) (23) (24) (25) . Furthermore, a decrease in CD40 ligand expression by activated T cells from patients with common variable immunodeficiency may be responsible, in part, for the hypogammaglobulinemia and antibody deficiency observed in these patients (26) .
In this study, we examined the hypothesis that the immaturity in immunoglobulin production, particularly of classes other than IgM, by neonates reflects not only the limited capacity of neonatal T cells to produce critical cytokines, but also a diminished ability to provide cognate help to B cells through CD40. We 1% BSA, serially diluted test samples or standards (purified from human sera) were added to each well and cultured at 37°C for 2 h. IgG, IgA, and IgM standards were purchased from Kent Laboratories (Kent, WA). IgE standard was purchased from Pharmacia AB (Uppsala, Sweden). After washing, secondary antibodies were added and plates were incubated for 2 h at 37°C. Secondary antibodies used were as follows: alkaline phosphatase-conjugated goat anti-human IgG (Cappel Laboratories), alkaline phosphatase-conjugated goat anti-human IgA (Sigma Chemical Co.), alkaline phosphatase-conjugated goat anti-human IgM (Sigma Chemical Co.), or biotin-conjugated goat anti-human IgE (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD). For IgE measurement, plates were subsequently incubated with alkaline phosphatase-conjugated extravidin (Sigma Chemical Co.). The substrate solution contained p-nitrophenyl phosphate disodium 1 mg/ml (Sigma Chemical Co.) in carbonate buffer, pH 9.8, with 10 mM MgCl26H2O.
Assay of T cell helper activity. Freshly isolated or mitogen-primed T cells obtained from adult peripheral blood or cord blood were cultured at 1-3 x 106 cells/ml in complete medium with 10 ng/ml PMA and Statistics. Data were compared using the Student's t test, MannWhitney U Test, and StatView 4.01 software (Abacus Concepts Inc., Berkeley, CA).
Results
Diminished expression of CD40 ligand by activated neonatal T cells. CD40 ligand expression by purified neonatal and adult T cells activated with PMA and ionomycin for 8 h was assessed by a CD40-Ig binding assay. A representative experiment is shown in Fig. 1 . The proportion of neonatal T cells expressing CD40 ligand (9.0%, Fig. 1 B) was less than that of adult T cells (54.0%, Fig. 1 A) , which were processed in parallel. This diminished expression was reflected in both fluorescence intensity and percentage of positively stained cells. Diminished CD40 ligand expression was not due to a global defect of activation, since the early T cell activation marker, CD69, was expressed equally well by neonatal (99.4%, Fig. 1 D) and adult T cells (98.4%, Fig. 1 C) . When analyzed as a group, the percentage of neonatal T cells expressing CD40 ligand (geometric mean, 12.6%; 97% confidence limits, 6.5-24.5%, n = 12) was significantly less (P < 0.005, Mann-Whitney U Test) than that of adult T cells (geometric mean, 49.5%; 97% confidence limits, 37.1-66.2%, n = 12). As apparent in Fig. 1 ligand expression in both neonatal and adult T cells was observed after 6-8 h of activation. Throughout the culture period, neonatal T cells expressed lower amounts of CD40 ligand than adult T cells, while the level of CD69 was comparable (Fig. 2) .
Purified neonatal and adult T cells were activated and double stained by anti-CD4 and CD40-Ig (Fig. 3, A and B) . More than 80% of adult CD4 + T cells expressed CD40 ligand. Small populations of CD4 -adult T cells expressed CD40 ligand (Fig.  3 A) . In contrast, only 37% of activated neonatal T cells positive for CD4 expressed CD40 ligand, and these cells expressed less CD40 ligand, as demonstrated by the intensity of fluorescent staining, than the activated adult CD4 + T cells. Neonatal CD4 -T cells did not express CD40 ligand (Fig. 3 B) .
CD4+ T cells, enriched by negative selection, were double stained with anti-CD45RA mAb and CD40-Ig. CD40 ligand was equally expressed by CD45RA+ and CD45RA -adult CD4+ T cells (Fig. 4 C) . Concordantly, when adult CD4+ cells were stained with anti-CD45RO mAb, both CD45RO+ and CD45RO-subsets expressed similar amounts of CD40 ligand (data not shown). As previously noted, most neonatal CD4+ T cells were CD45RA+ (6, 33, 34 cells within adult CD45RA+ CD4+ subset expressed CD40 ligand, only 29% of the cell within neonatal CD45RA+ CD4+ subset expressed CD40 ligand (Fig. 3 D) . Similar results were obtained by three independent experiments (data not shown). Diminished expression of CD40 ligand by activated thymocytes. CD40 ligand expression was not detected in resting whole thymocytes or total thymocytes activated with PMA and ionomycin for 8 h (Fig. 4, A and B ) or 4 and 16 h (data not shown). Enriched CD4 single-positive thymocytes that were activated with PMA and ionomycin for 8 h (Fig. 4 D) (Fig. 4 C) . The intensity of CD40-Ig binding by activated CD4 single-positive thymocytes varied slightly (n = 5, data not shown); Fig. 4 shows the preparation with the greatest CD40-Ig binding. Clearly CD40 ligand expression by activated CD4 single-positive thymocytes (17%, Fig. 4 D) was markedly lower than that seen with adult T cells processed in parallel (52%, Fig. 4 F) . In contrast to CD40-Ig binding, CD69 expression by thymocytes and adult T cell was comparable (data not shown).
CD40 ligand mRNA is diminished in activated neonatal T cells and thymocytes. Northern analysis of total cellular RNA from both neonatal and adult T cells activated with PMA and ionomycin revealed that CD40 ligand mRNA peaked at 2 h of stimulation and was diminished in neonatal T cells at each time point studied (Fig. 5, A (35) and to secrete additional lymphokines, e.g., 11L-4 and IFN-y (6, 7). We studied in parallel neonatal and adult T cells from five individuals each, cultured in the presence of Con A, PMA, and 11L-2 for 3 d, washed, and allowed to quiesce for an additional 2 d in the presence of IL-7. Cells were then restimulated with PMA and ionomycin. The proportion of activated neonatal T cells expressing CD40 ligand by FACS® analysis (2.9%, Fig. 6 B) increased with in vitro priming (50.5%, Fig. 6 D) to a level comparable with that of either freshly isolated, activated adult T cells (35.6%, Fig. 6 A) Fig. 7 shows representative results from one of four independent experiments. Neonatal T cells induced significantly less IgE than adult T cells if freshly isolated cells were studied (P < 0.05, Student's t test). However, if mitogen-primed cells were examined, neonatal T cells induced IgE amounts comparable with those induced by the freshly isolated adult T cells.
B cell proliferation and IgEproduction in response to sgp39 and IL-4 is comparable in both neonatal and adult T cells. Purified B cells obtained from neonatal and adult peripheral blood were cultured without (-) or with (+) sgp39 and 11L-4; cell proliferation was assessed after 4 d of culture (Fig. 8 A) and IgE production was assessed after 12 d of culture (Fig. 8  B) . Difference between the [3H] thymidine uptake sgp39 and IL-10 ( Fig. 9, top) . Cord blood B cells from 8 out of 13 neonates produced amounts of IgM comparable with adult B cells, and 5 produced lower but detectable levels of IgM. In contrast, the amounts of IgG and IgA produced by stimulated neonatal B cells were consistently and markedly lower than those produced by adult B cells. B cells obtained from 10 out of 13 neonates failed to produce detectable amounts of IgG, and 6 out of 13 failed to produce detectable levels of IgA (Fig.  9, bottom) . Since IL-1O (at a concentration of 10 ng/ml), unlike 1L-4, has little, if any, capacity to induce Ig class switch (15) , these results are consistent with a paucity of neonatal B cells that have undergone switching to IgG or IgA in vivo (1, 3). As shown in Table I (e.g., thymocytes), is expressed by the majority of neonatal CD45RA+ CD4+ T cells but not by adult CD45RA+ CD4+ T cells (35) . Neither neonatal nor adult CD45RA + CD4+ T cells provide efficient help for B cell immunoglobulin production (35, 36) . However, neonatal CD45RA+ CD4+ T cells, but not adult CD45RA + CD4 + T cells, suppress B cell responses (35) . From these observations, it is suggested that, although neither cell produces cytokines critical to Ig production, neonatal CD45RA + CD4+ T cells are more immature than the adult CD45RA + CD4 + T cells, and that a portion of neonatal CD45RA+ CD4 + cells may mature with age without losing CD45RA expression (35) . Alternatively, the adult CD45RA+ CD4+ population may contain a subset that reverted from 72 Nonoyama et al. To test if the lack of antigen exposure is involved in the inability of neonatal T cells to express CD40 ligand after activation with PMA and ionomycin, we used an in vitro priming culture system. After priming culture, the percentage of neonatal T cells expressing CD40 ligand after activation increased threefold from 15 to 47% (Fig. 6 , B and D) comparable with freshly isolated (50%, Fig. 6 A) or primed adult T cells (57%, Fig. 6  C) . Furthermore, we observed that primed neonatal T cells exhibited helper activity comparable with adult T cells (Fig.  7) . Consistent with these findings is the observation by Clement et al. (35) that neonatal CD45RA+ CD4+ T cells, if activated with PHA and cultured in the presence of IL-2, acquire the helper cell function of inducing Ig production by B cells. Because CD40 ligand has been shown to induce B cell activation and Ig synthesis via CD40 in the presence of cytokines, our data suggest that acquisition of this helper activity may, in part, be due to the enhanced expression of CD40 ligand by primed neonatal T cells. These results also suggest that decreased expression of CD40 ligand by neonatal T cells, like the decreased expression of IL-4 and IFN-y (6, 7), is due to the lack of "education" by exposure to exogenous antigen.
To assess neonatal B cell function, we cultured purified B cells in the presence of sgp39, the physiologic ligand of CD40, and cytokines. The combination of sgp39 and IL-4 induced proliferation and IgE production in amounts comparable with adult B cells and the production of a modest amount of IgG. (1) , and that IL-10, at the dose used, has little capacity to induce Ig class switching (15) , while IL-4 induces switching potently to IgE and modestly to IgG production (12, 14) . Similar results were reported by Splawski et al. (2) ( 16, (22) (23) (24) (25) . Furthermore, a subset of patients with common variable immunodeficiency and decreased serum Ig has depressed CD40 ligand expression (26) . These findings indicate that CD40 ligand plays an important role in the induction of B cell maturation in vivo. It is of interest that both CD40 ligand and IL-4, which are important for Ig class switching, are expressed or produced in decreased levels by neonatal T cells. Together, these observations suggest that immaturity of neonatal T cells, as manifested by decreased expression of CD40 ligand and decreased production of cytokines (e.g., reduced IL-4 and IFN-'y), is the major cause of the functional B cell immaturity in neonates. Like the production and secretion of cytokines, the ability to express CD40 ligand could be induced by priming of neonatal T cells, suggesting that the lack of exposure to exogenous antigens is a principal cause of this immaturity.
